Hempfusion Wellness Inc. (CBDHF)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Hempfusion Wellness Inc. (CBDHF) trades at $0.00 with AI Score 67/100 (Grade B+). Hempfusion Wellness Inc. is a Canadian health and wellness company specializing in hemp-based natural supplements and probiotic products for the U. S. Market cap: $1,635, Sector: Healthcare.
Price live · AI analysis from Jun 14, 2026Analyst Coverage for CBDHF: CBDHF does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates CBDHF against Healthcare peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.
CBDHF: the 5 perspectives are evenly split. Dominant signal: Seth Klarman bearish.
How is this calculated? →Hempfusion Wellness Inc. (CBDHF) Healthcare & Pipeline Overview
Hempfusion Wellness Inc. is a Canadian health and wellness company focused on formulating and distributing hemp-based natural supplements and probiotic products across the United States. Operating in the specialty and generic drug manufacturing sector, it leverages a multi-channel distribution strategy to reach consumers through e-commerce, healthcare practitioners, and traditional retail outlets, offering a diverse portfolio under brands like HempFusion and Probulin.
What Is the Investment Thesis for CBDHF?
Hempfusion Wellness Inc. operates within the expanding health and wellness supplement market, focusing on hemp-based and probiotic products distributed across the United States. The company's diversified brand portfolio, including HempFusion and Probulin, coupled with its multi-channel distribution strategy encompassing e-commerce, doctor practitioners, and mass retail, provides a broad market reach. Key value drivers include the increasing consumer demand for natural health solutions and the potential for product innovation within the specialty supplement sector. However, the company faces significant financial challenges, as evidenced by a negative Return on Equity of -200.9% and a high Debt-to-Equity ratio of 3.57, indicating substantial leverage and profitability issues. Its Gross Margin of 27.0% suggests some operational efficiency in product costing, but this is overshadowed by overall unprofitability. The extremely negative Beta of -34.72 is highly unusual and suggests extreme inverse volatility or data anomaly, requiring careful scrutiny. Future growth catalysts could include successful new product launches, expansion into new retail partnerships, and increased consumer adoption of its specialized product lines. The company's small market capitalization ($0.00B) and OTC trading status imply higher risk and potential liquidity challenges, requiring investors to conduct thorough due diligence on its financial health and operational execution.
Based on FMP financials and quantitative analysis
CBDHF Key Highlights
- Gross Margin of 27.0%: Indicates the company's profitability at the product level, covering direct costs of goods sold.
- Return on Equity (ROE) of -200.9%: Reflects significant unprofitability relative to shareholder equity, signaling substantial financial challenges.
- Debt-to-Equity (D/E) Ratio of 3.57: Points to a highly leveraged capital structure, with debt financing a substantial portion of assets, increasing financial risk.
- Market Capitalization of 2K: Suggests a very small company valuation, often associated with micro-cap or penny stocks, implying higher volatility and risk.
- Employee Count of 47: Indicates a relatively small operational footprint, managing product formulation, marketing, and distribution with a focused team.
Who Are CBDHF's Competitors?
CBDHF is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| ALVO Alvotech | $3.51 | -2.77% | $1.19B | 69 |
| AERI Aerie Pharmaceuticals, Inc. | $15.25 | +0.00% | 68 | |
| KIN Kindred Biosciences, Inc. | $9.25 | +0.11% | 68 | |
| CNVCF BioHarvest Sciences Inc. | $6.30 | +0.00% | $109.16M | 66 |
| GDNSF Goodness Growth Holdings, Inc. | $0.45 | +0.00% | $61.05M | 64 |
| AVDL Avadel Pharmaceuticals plc | $21.64 | +0.00% | $2.12B | 64 |
| GENH Generation Hemp, Inc. | $0.22 | +0.00% | $25.34M | 63 |
| CAMRF Camurus AB (publ) | $60.00 | -1.66% | $3.60B | 63 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are CBDHF's Key Strengths?
- Diverse product portfolio under multiple brands (HempFusion, Probulin, HF Labs, Biome Research).
- Multi-channel distribution strategy including e-commerce, doctor practitioners, and broad retail.
- Focus on growing health and wellness segments (hemp-based and probiotics).
- Established presence in the U.S. market.
What Are CBDHF's Weaknesses?
- Significant unprofitability with a negative Return on Equity of -200.9%.
- High financial leverage indicated by a Debt-to-Equity ratio of 3.57.
- Small market capitalization ($0.00B) and OTC trading status, implying limited liquidity and higher risk.
- Unknown disclosure status on the OTC market, potentially limiting investor transparency.
What Could Drive CBDHF Stock Higher?
- Expansion of Retail Partnerships: Securing new distribution agreements with major food, drug, or mass-market retailers could significantly increase product visibility and sales volume across the U.S.
- Launch of New Probiotic Formulations: Introducing innovative probiotic products under the Probulin brand, targeting specific health benefits, could capture new market segments and drive revenue growth.
- Growth in E-commerce Sales Channels: Continued optimization of its e-commerce platforms and digital marketing efforts could lead to sustained growth in direct-to-consumer sales, enhancing margins.
- Regulatory Clarity for Hemp-Based Products: Any favorable legislative or regulatory developments regarding hemp-derived supplements in the U.S. could reduce operational uncertainties and open new market opportunities.
What Are the Key Risks for CBDHF?
- Financial-distress signal — its Altman Z-Score of -6.15 sits in the distress zone (elevated bankruptcy risk).
- Significant Financial Leverage and Unprofitability: The high Debt-to-Equity ratio of 3.57 and negative ROE of -200.9% indicate substantial financial risk and ongoing challenges in achieving profitability.
- Intense Competition in Health & Wellness Market: The fragmented and competitive nature of the supplement industry, with numerous players, poses a constant threat to market share and pricing power.
- Regulatory Changes for Hemp-Based Products: Evolving or stricter regulations concerning the production, marketing, and sale of hemp-derived supplements could negatively impact operations and product availability.
- Low Liquidity and Transparency of OTC Trading: Trading on the "OTC Other" tier with an unknown disclosure status presents risks of low trading volume, wide bid-ask spreads, and difficulty in accessing crucial financial information for investors.
- Consumer Perception Shifts: Changes in consumer attitudes towards natural supplements or negative publicity related to hemp-based products could reduce demand for Hempfusion Wellness Inc.'s offerings.
What Are the Growth Opportunities for CBDHF?
- Expansion of E-commerce Presence: The global e-commerce market for health and wellness products continues to expand rapidly, projected to reach significant market sizes in the coming years. Hempfusion Wellness Inc. can capitalize on this by investing in digital marketing, optimizing its e-commerce platforms for user experience, and expanding its online product offerings. A stronger online presence allows for direct consumer engagement, potentially higher margins, and broader geographic reach beyond traditional retail limitations, directly addressing a growing consumer preference for online purchasing of health supplements.
- New Product Development in Specialized Categories: The health and wellness industry is constantly seeking innovative solutions. Hempfusion Wellness Inc. can leverage its expertise in hemp-based and probiotic formulations to introduce new, specialized products targeting specific health concerns or demographic groups. For example, developing products for cognitive health, sleep support, or women's health within its existing brand architecture could unlock new revenue streams. This strategy allows the company to capture emerging market trends and maintain a competitive edge by offering novel, research-backed solutions to consumers.
- Deepening Doctor Practitioner Partnerships: The professional channel, involving doctor practitioners, offers a high-trust environment for health supplement recommendations. By strengthening relationships with healthcare professionals, Hempfusion Wellness Inc. can increase product adoption through trusted endorsements. This involves providing educational resources to practitioners, participating in medical conferences, and developing clinically supported formulations. This channel can drive consistent, high-value sales, as practitioner recommendations often lead to loyal customer bases and higher average order values, tapping into a segment that values expert guidance.
- Broadening Retail Distribution (Food, Drug, Mass, Convenience): While already present in these channels, there remains significant opportunity for deeper penetration and expansion into new retail chains or increasing shelf space within existing partners. The food, drug, mass, and convenience retail sectors represent a vast market for impulse and routine purchases of health supplements. Negotiating favorable placement, running targeted in-store promotions, and expanding geographical reach within these retail formats can substantially increase brand visibility and sales volume, reaching a wider consumer base that prefers physical retail shopping.
- Geographic Market Expansion within the U.S.: The United States is a large and diverse market, and while Hempfusion Wellness Inc. operates within it, there may be untapped regional markets or specific states where its products have lower penetration. A targeted strategy to expand distribution and marketing efforts into these underserved areas could unlock significant growth. This involves market research to identify high-potential regions, establishing new distribution networks, and tailoring marketing campaigns to local demographics and preferences, thereby maximizing the company's reach across the entire U.S. landscape.
What Opportunities Does CBDHF Have?
- Growing consumer demand for natural health and wellness supplements.
- Expansion of product lines within existing brands or introduction of new specialized products.
- Deepening penetration in existing retail channels and forging new partnerships.
- Leveraging e-commerce growth to expand direct-to-consumer sales and market reach.
What Threats Does CBDHF Face?
- Intense competition from both established pharmaceutical companies and emerging supplement brands.
- Evolving and potentially restrictive regulatory landscape for hemp-based products.
- Consumer perception shifts or adverse publicity regarding natural supplements.
- Economic downturns impacting discretionary spending on health products.
What Are CBDHF's Competitive Advantages?
- Diversified Brand Portfolio: Ownership of established brands like HempFusion (hemp-based) and Probulin (probiotics/digestive health) creates distinct market identities and consumer loyalty across different wellness categories.
- Multi-Channel Distribution Network: A robust distribution strategy encompassing e-commerce, doctor practitioners, and broad retail (food, drug, mass, convenience) provides wide market access and reduces reliance on a single sales channel.
- Product Formulation Expertise: Specialization in formulating both hemp-based natural supplements and probiotic products demonstrates specific scientific and development capabilities in niche, growing health segments.
- Regulatory Navigation: Experience in operating within the evolving regulatory landscape for hemp-based products in the U.S. can represent a barrier to entry for new competitors.
What Does CBDHF Do?
Hempfusion Wellness Inc. is a health and wellness supplement company headquartered in Vancouver, Canada, dedicated to the formulation, marketing, and distribution of a diverse range of natural supplements and probiotic products within the United States market. Established to capitalize on the growing demand for natural health solutions, the company has evolved to encompass a broad product portfolio catering to various consumer needs. Its core offerings include tinctures, capsules, and topical creams and gel products, all marketed under its flagship HempFusion brand, which leverages the therapeutic potential of hemp-based compounds. Beyond its hemp-centric line, Hempfusion Wellness Inc. has strategically diversified its product offerings to include digestive enzymes and probiotics, as well as specialized skin care products, primarily under the Probulin brand. This expansion positions the company to address a wider spectrum of wellness concerns, from gut health to dermatological care, thereby broadening its market appeal. Additionally, the company operates under the HF Labs and Biome Research branded products, further indicating a commitment to research-backed formulations and product innovation in the health supplement space. The company employs a comprehensive, multi-channel distribution strategy to ensure widespread product availability. Its products are accessible directly to consumers through its dedicated e-commerce websites, providing convenience and direct engagement. Furthermore, Hempfusion Wellness Inc. partners with doctor practitioners, integrating its products into professional healthcare recommendations and leveraging trusted medical channels. A significant portion of its distribution also extends to various food, drug, mass, and convenience market retailers, ensuring a strong presence in mainstream consumer purchasing environments. This strategic blend of direct-to-consumer, professional, and retail distribution channels underscores Hempfusion Wellness Inc.'s approach to maximizing market penetration and consumer reach in the competitive health and wellness industry. The company currently manages a team of 47 employees, supporting its operations from its Canadian base to serve the U.S. market.
What Products and Services Does CBDHF Offer?
- Formulates and develops health and wellness supplements.
- Markets and distributes hemp-based natural supplements.
- Markets and distributes probiotic products.
- Offers tinctures, capsules, and topical creams under the HempFusion brand.
- Provides digestive enzymes, probiotics, and skin care products under the Probulin brand.
- Sells products through its e-commerce websites directly to consumers.
- Distributes products via doctor practitioners for professional recommendations.
- Supplies products to various food, drug, mass, and convenience market retailers.
How Does CBDHF Make Money?
- Product Development & Manufacturing: Hempfusion Wellness Inc. formulates and develops a range of natural health supplements, including hemp-based and probiotic products.
- Multi-Channel Sales: The company generates revenue through direct-to-consumer sales via e-commerce, professional sales through doctor practitioners, and wholesale sales to various retail chains (food, drug, mass, convenience).
- Brand Portfolio Management: Revenue is driven by sales across multiple distinct brands such as HempFusion, Probulin, HF Labs, and Biome Research, each targeting specific health needs.
- Distribution & Logistics: The company manages the distribution of its products across the United States, ensuring availability through its diverse sales channels.
What Industry Does CBDHF Operate In?
Hempfusion Wellness Inc. operates within the "Drug Manufacturers - Specialty & Generic" industry, specifically targeting the health and wellness supplement segment, which is characterized by dynamic consumer preferences and evolving scientific understanding. The broader market for natural supplements, including hemp-based products and probiotics, has experienced consistent growth driven by increasing consumer awareness of preventative health, gut health, and natural alternatives to traditional pharmaceuticals. This trend positions Hempfusion Wellness Inc. to potentially benefit from a growing addressable market. However, the industry is highly fragmented and competitive, with numerous players ranging from large pharmaceutical companies with diversified portfolios to specialized supplement brands. Competition arises from both established brands and emerging direct-to-consumer companies, all vying for market share through product innovation, marketing, and distribution reach. Hempfusion Wellness Inc. differentiates itself through its dual focus on hemp-based and probiotic products and its multi-channel distribution strategy, aiming to carve out a niche in a crowded landscape. The company's success is intrinsically linked to its ability to navigate regulatory complexities surrounding hemp products and to effectively market its specialized offerings against a backdrop of diverse competitors.
Who Are CBDHF's Key Customers?
- Health-Conscious Consumers: Individuals seeking natural supplements for general wellness, specific health concerns, or preventative care.
- Patients and Clients of Healthcare Practitioners: Consumers who receive product recommendations from doctors, nutritionists, or other health professionals.
- Retail Shoppers: Customers who purchase health supplements from mainstream food, drug, mass-market, and convenience stores.
- E-commerce Shoppers: Consumers who prefer the convenience of purchasing health and wellness products online directly from the company's websites.
ROE 0%Key Financial Metrics
Return on equity for Hempfusion Wellness Inc. stands at 0.0%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 0.0%, showing how much profit it generates from its asset base. A current ratio of 0.78 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 0.0%, the inverse of the P/E and a quick read on earnings relative to price.
Hempfusion Wellness Inc. (CBDHF) Valuation Context
Valued at 2K, CBDHF is classified as a micro-cap stock. Relative to its peer group, CBDHF's quantitative score of 67/100 is roughly in line with the peer average of 67/100.
Company Profile
Hempfusion Wellness Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in Vancouver, CA. The company is led by CEO Maria Leal. CBDHF has traded publicly since 2021.
F-Score 4/9Financial Health
Hempfusion Wellness Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -6.15 places it in the distress zone, a signal of elevated financial risk.
CBDHF Financials
Bull Case vs Bear Case
Bull Case
- Diverse product portfolio under multiple brands (HempFusion, Probulin, HF Labs, Biome Research).
- Multi-channel distribution strategy including e-commerce, doctor practitioners, and broad retail.
- Focus on growing health and wellness segments (hemp-based and probiotics).
- Established presence in the U.S. market.
Bear Case
- Significant unprofitability with a negative Return on Equity of -200.9%.
- High financial leverage indicated by a Debt-to-Equity ratio of 3.57.
- Small market capitalization ($0.00B) and OTC trading status, implying limited liquidity and higher risk.
- Unknown disclosure status on the OTC market, potentially limiting investor transparency.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · July 2026
CBDHF Latest News
No recent news available for CBDHF.
CBDHF Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for CBDHF.
Price Targets
Wall Street price target analysis for CBDHF.
CBDHF MoonshotScore
What does this score mean?
The MoonshotScore rates CBDHF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Maria Leal
Chief Executive Officer
Maria Leal serves as the Chief Executive Officer of Hempfusion Wellness Inc., overseeing the strategic direction and operational management of the company's health and wellness supplement business. Her leadership is central to the company's efforts in formulating, marketing, and distributing its hemp-based natural supplements and probiotic products across the United States. With a focus on managing the company's 47 employees, her role encompasses driving product innovation, expanding market reach through diverse distribution channels, and navigating the competitive landscape of the specialty and generic drug manufacturing sector.
Track Record: Under Maria Leal's leadership, Hempfusion Wellness Inc. has maintained its focus on a multi-channel distribution model, including e-commerce, doctor practitioners, and various retail outlets. Her tenure has seen the company continue to offer a diverse product portfolio under brands like HempFusion and Probulin, aiming to capture market share in the evolving health and wellness industry. She is responsible for the strategic decisions impacting the company's operational efficiency and market positioning.
CBDHF OTC Market Information
Hempfusion Wellness Inc. trades on the "OTC Other" tier of the OTC market. This tier typically includes companies that do not meet the disclosure or financial requirements for higher tiers like OTCQX or OTCQB, or those that choose not to provide extensive public information. Unlike exchanges such as NYSE or NASDAQ, which have stringent listing standards regarding financial health, corporate governance, and minimum share prices, the OTC market, particularly the "OTC Other" tier, has significantly fewer requirements. This often results in less transparency and higher risk for investors compared to companies listed on major exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited public information and unknown disclosure status, hindering informed decision-making.
- Significantly lower liquidity compared to exchange-listed stocks, making trading difficult.
- Increased volatility and potential for price manipulation due to fewer regulatory oversight.
- Difficulty in obtaining financing or attracting institutional investors due to OTC status.
- Higher transaction costs and wider bid-ask spreads for investors.
- Verify any available financial statements (even if unofficial or limited).
- Research management's background and track record beyond provided data.
- Assess the company's operational status and actual product distribution.
- Investigate any news or press releases from the company or third parties.
- Understand the specific regulatory environment for hemp-based products.
- Evaluate the company's competitive positioning within its niche markets.
- Consider the potential for delisting or further market tier downgrades.
- Clear business description of formulating, marketing, and distributing products.
- Identified brands (HempFusion, Probulin, HF Labs, Biome Research) suggesting active operations.
- Mention of specific distribution channels (e-commerce, doctor practitioners, retailers).
- Headquarters location and employee count provided, indicating a physical presence and workforce.
What Investors Ask About Hempfusion Wellness Inc. (CBDHF) — Healthcare
What does Hempfusion Wellness Inc. do?
Hempfusion Wellness Inc. is a Canadian-based health and wellness supplement company that specializes in the formulation, marketing, and distribution of natural supplements in the United States. Its product portfolio is primarily divided into hemp-based offerings, including tinctures, capsules, and topical creams under the HempFusion brand, and probiotic products, digestive enzymes, and skincare items under the Probulin brand. The company also operates under HF Labs and Biome Research. Hempfusion Wellness Inc. employs a multi-channel distribution strategy, selling its products through its dedicated e-commerce websites, via doctor practitioners, and through a wide network of food, drug, mass, and convenience market retailers, aiming for broad consumer access.
What are the main risks for CBDHF?
Hempfusion Wellness Inc. faces several significant risks. Financially, the company exhibits substantial leverage with a Debt-to-Equity ratio of 3.57 and a deeply negative Return on Equity of -200.9%, indicating ongoing profitability challenges and high financial risk. Operationally, it contends with intense competition within the fragmented health and wellness supplement market, which could pressure market share and pricing. Furthermore, the evolving regulatory landscape for hemp-based products in the U.S. poses a continuous threat of changes that could impact product formulation, marketing, or distribution. As an OTC-traded stock with an unknown disclosure status, investors face risks related to low liquidity, potential price volatility, and limited access to comprehensive financial information.
How does Hempfusion Wellness Inc. navigate the regulatory landscape for hemp-based products?
Hempfusion Wellness Inc. operates within the United States market, where the regulatory environment for hemp-based products, particularly those containing CBD, is complex and continuously evolving. The company's strategy involves adhering to current federal and state guidelines for dietary supplements and cosmetic products, which can vary significantly. While specific details of their compliance efforts are not provided, operating in this sector necessitates careful product labeling, marketing claims substantiation, and potentially adapting formulations to meet new standards. The ongoing shifts in FDA guidance and state-level legislation for hemp-derived compounds mean that Hempfusion Wellness Inc. must maintain vigilance and flexibility to ensure its products remain compliant and accessible across its diverse distribution channels, mitigating potential legal and operational risks.
What is the significance of Hempfusion Wellness Inc.'s multi-channel distribution strategy?
Hempfusion Wellness Inc.'s multi-channel distribution strategy, encompassing e-commerce websites, doctor practitioners, and various food, drug, mass, and convenience market retailers, is crucial for its market penetration and resilience. This approach allows the company to reach diverse consumer segments: direct-to-consumer online sales offer convenience and potentially higher margins; partnerships with doctor practitioners leverage professional trust and recommendations for specialized products; and broad retail presence ensures accessibility and brand visibility in everyday shopping environments. By not relying on a single channel, the company diversifies its revenue streams, mitigates risks associated with any one channel's performance, and maximizes its reach across the competitive U.S. health and wellness market, catering to different consumer purchasing preferences.
What are the key factors to evaluate for CBDHF?
Hempfusion Wellness Inc. (CBDHF) holds an AI score of 67/100 (moderate). Not financial advice.
How frequently does CBDHF data refresh on this page?
CBDHF prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven CBDHF's recent stock price performance?
Hempfusion Wellness Inc. (CBDHF) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diverse product portfolio under multiple brands (HempFusion, Probulin, HF Labs, Biome Research). See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider CBDHF overvalued or undervalued right now?
Valuing Hempfusion Wellness Inc. (CBDHF) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial metrics provided, impacting depth of financial analysis.
- No FMP PEER TICKERS provided, so competitor analysis is limited to general industry context.
- OTC disclosure status is unknown, which limits transparency and detailed risk assessment.
- Beta value is extremely negative (-34.72), which is highly unusual and may indicate data anomaly or extreme inverse correlation not typically seen in healthy companies; interpreted as a significant risk factor.